Skip to Main Content

From AHLA’s Payers, Plans, and Managed Practice Group: Lowering Drug Prices with the Anti-Kickback Statute: Future and Impact of HHS Final Rule to Disrupt Drug Formulary Rebates

  • January 14, 2021

You must be logged in to access this content.